Trademark Trial and Appeal Board Electronic Filing System. http://estta.uspto.gov
`ESTTA490034
`ESTTA Tracking number:
`08/20/2012
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`Notice of Opposition
`
`Notice is hereby given that the following party opposes registration of the indicated application.
`Opposer Information
`
`Name
`Granted to Date
`of previous
`extension
`Address
`
`Novartis AG
`08/22/2012
`
`CH-4002
`Basel,
`SWITZERLAND
`
`Attorney
`information
`
`John P. Margiotta
`Fross Zelnick Lehrman & Zissu, PC
`866 United Nations Plaza
`New York, NY 10017
`UNITED STATES
`jm@fzlz.com, agreenberg@fzlz.com Phone:2128135900
`Applicant Information
`
`85469498
`08/20/2012
`
`Application No
`Opposition Filing
`Date
`Applicant
`
`Publication date
`Opposition
`Period Ends
`M&R of Fredericktown Limited, Inc.
`895 Home Avenue
`Akron, OH 44310
`UNITED STATES
`Goods/Services Affected by Opposition
`
`04/24/2012
`08/22/2012
`
`Class 010.
`All goods and services in the class are opposed, namely: Compression socks for medical or
`therapeutic use; medical compression stockings and tights; medical hosiery, namely, compression
`sleeves, socks and hosiery
`
`Grounds for Opposition
`
`Priority and likelihood of confusion
`Dilution
`
`Trademark Act section 2(d)
`Trademark Act section 43(c)
`
`Marks Cited by Opposer as Basis for Opposition
`
`U.S. Registration
`No.
`Registration Date
`
`2336960
`
`04/04/2000
`
`Word Mark
`
`NOVARTIS
`
`Application Date
`
`07/09/1996
`
`Foreign Priority
`Date
`
`02/15/1996
`
`

`
`NONE
`
`Class 001. First use:
`[ chemicals and chemical preparations for use in industry, agriculture,
`horticulture and forestry, namely, chemicals for use in manufacturing optical
`lenses; Adjuvants for use in manufacturing agricultural preparations; Adjuvants
`for use in manufacturing pharmaceutical preparations; Chemical additives for
`use in manufacturing - pharmaceutical preparations, defoliants, wound pastes
`for trees and plants, plant growth regulators, preparations for the treatment of
`seeds, preparations for the protection of seeds and plants against plant
`pathogens, plant protection agents of a prophylactic nature; and Manures ]
`Class 005. First use:
`pharmaceutical preparations for the treatment of - dermatological,
`cardiovascular, hematological, bone, respiratory, central nervous system,
`endocrinological, circulatory, gastroenterological, hormonal and diabetic
`disorders, coughs, colds, influenza, headaches, stomach and digestive
`disorders, muscular and/or rheumatic disorders, anti-inflammatory agents,
`immune system disorders and related diseases, allergic reactions, metabolic
`disorders, anti-infectives, occular disorders, and for use in oncology; diagnostic
`preparations and/or reagents for clinical or medical laboratory use; Contact lens
`and eyecare solutions and preparations, namely, disinfectants, cleaning
`solutions, saline solutions and wetting solutions; Nicotine for medicinal purposes
`in liquid, pill, tablet, caplet, powder or transdermal patch form; [ Hormones; ]
`Dietetic substances for medical purposes, namely, nutritional, vitamin, [ herbal
`and ] mineral supplements and preparations, nutritional drink mix for use as a
`meal replacement, [ nutritional supplements in snack bar form for use as a meal
`replacement; ] Food and beverages for [ babies, ] nfants and invalids, namely, [
`baby food, infant formula, ] food for enteral administration and food for medically
`restricted diets; and [ Pesticides, ] fungicides, [ herbicides ] and insecticides, all
`for commercial, [ agricultural ] and/or domestic use
`Class 009. First use:
`[ contact lenses; Eyeglasses; Sunglasses; and Optical lenses not for medical
`use ]
`Class 010. First use:
`[ artificial or biological skin tissue for subsequent implantation; Intraocular lenses
`
`] C
`
`lass 029. First use:
`[ prepared entrees consisting primarily of meat, fish, poultry, game and/or
`vegetables; Meat extracts; Preserved, dried, frozen or cooked fruits and
`vegetables; Jams and fruit or vegetable preserves; Fruit-based snack foods;
`Fruit toppings; Dairy products, excluding ice cream, ice milk and frozen yogurt;
`Milk ]
`Class 030. First use:
`[ ready to eat snack bars made from combinations of cereal, fruit, grains and
`nuts; Breakfast and processed cereals; Cereal based snack foods; Bread;
`Biscuits; Chocolate; Candy; Cocoa; Sugar; Tapioca; Sago; Rusks; Desserts,
`
`Design Mark
`
`Description of
`Mark
`Goods/Services
`
`

`
`namely, cakes and puddings; Malt for food purposes; Ice cream, frozen yogurt,
`ice milk and ice cream substitute; Chocolate syrup; Corn syrup; and Food
`additives for non-nutritional purposes for use as a flavoring, ingredient or filler ]
`Class 031. First use:
`[ bran, cereal and protein based foodstuffs for animals; Vegetable, fruit and
`flower seeds for agricultural and horticultural purposes; Fresh fruits and
`vegetables; Living plants and live flowers ]
`Class 032. First use:
`[ non-alcoholic beverages, namely, soft drinks, fruit drinks, fruit juices;
`Concentrates, syrups or powders used in the preparation of soft drinks; and Fruit
`syrups used in the preparation of soft drinks ]
`Class 042. First use:
`[ engineering services; plant, tree and seed breeding services; Horticultural
`services; Printing; and Material testing ]
`
`U.S. Registration
`No.
`Registration Date
`
`Word Mark
`Design Mark
`
`2997235
`
`09/20/2005
`
`NOVARTIS
`
`Application Date
`
`02/10/2004
`
`Foreign Priority
`Date
`
`NONE
`
`Description of
`Mark
`Goods/Services
`
`NONE
`
`Class 005. First use: First Use: 1997/09/30 First Use In Commerce: 1997/09/30
`Adjuvants for use with veterinary vaccines and veterinary vaccines for
`companion animals, farmed fish and livestock; veterinary products for
`companion animals, farmed fish and livestock, namely, cardiovascular treatment
`preparations, arthritis treatment preparations, renal treatment preparations,
`respiratory treatment preparations, reproductive treatment preparations, allergy
`treatment preparations, antibiotics, insecticides, pesticides and feed additives for
`veterinary use in the treatment of parasites, fleas, worms, renal diseases, heart
`diseases, allergic diseases, parasitic and bacterial infections, lameness,
`respiratory diseases, scours or enteritis, viral diseases, clostridial diseases,
`pinkeye, liver abscesses, influenza, pneumonia, mastitis, West Nile virus and
`erysipelas; insecticides and rodenticides for agricultural use, disinfectants for
`veterinary use
`
`Attachments
`
`75131409#TMSN.gif ( 1 page )( bytes )
`78365657#TMSN.jpeg ( 1 page )( bytes )
`Notice of Opposition (NOVARIS) (F1070820).PDF ( 16 pages )(572625 bytes )
`
`

`
`The undersigned hereby certifies that a copy of this paper has been served upon all parties, at their address
`record by First Class Mail on this date.
`
`Certificate of Service
`
`Signature
`Name
`Date
`
`/John P. Margiotta/
`John P. Margiotta
`08/20/2012
`
`

`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`NOVARTIS AG,
`
`Opposer,
`
`V.
`
`M&R OF FREDERICKTOWN LIMITED, INC.
`
`d.b.a. STRIDELITE,
`
`Applicant.
`
`NOTICE OF OPPOSITION
`
`Novartis AG (“Opposer”), a corporation organized and existing according to the laws of
`
`Switzerland, located and doing business at CH-4002, Basel, Switzerland, believes that it will be
`
`damaged by the issuance of a registration for the mark NOVARIS, applied for in Application
`
`Serial No. 85/469,498 for “compression socks for medical or therapeutic use; medical
`
`compression stockings and tights; medical hosiery, namely, compression sleeves, socks and
`
`hosiery” in International Class 10, and therefore opposes the same. As grounds for the
`
`opposition, Opposer, by its attorneys Fross Zelnick Lehrman & Zissu, P.C., alleges as follows:
`
`1.
`
`Opposer is the owner of the trademark and trade name NOVARTIS in connection
`
`with a wide variety of pharmaceutical preparations for human and Veterinary medicines.
`
`Opposer has used the mark NOVARTIS in commerce since at least as early as 1997, and the
`
`mark is now famous.
`
`2.
`
`Novartis is the owner of the following U.S. trademark registrations:
`
`0 NOVARTIS, Reg. No. 2,336,960, registered April 4, 2000 for pharmaceuticals in
`
`International Class 5.
`
`0 NOVARTIS, Reg. No. 2,997,235, registered September 20, 2005, for veterinary
`
`pharmaceuticals in International Class 5.
`
`(Fl0682J4l )
`
`

`
`3.
`
`These registrations are valid, subsisting and in full force and effect, and constitute
`
`evidence of the validity of the marks and of Opposer’s exclusive right to use them on the goods
`
`identified in the registrations. Both registrations have also become incontestable under
`
`Section 15 of the Trademark Act. Printouts from the United States Patent and Trademark
`
`Off1ce’s online databases reflecting these registrations are attached as Exhibit A.
`
`4.
`
`On information and belief, M&R of Fredericktown Limited, Inc. d.b.a. StrideLite
`
`(“Applicant”) is a corporation organized and existing according to the laws of Ohio, located and
`
`doing business at 895 Home Avenue, Akron, OH 44310.
`
`5.
`
`On November 10, 2011, Applicant filed Application Serial No. 85/469,498 to
`
`register the mark NOVARIS for use in connection with “Compression socks for medical or
`
`therapeutic use; medical compression stockings and tights; medical hosiery, namely,
`
`compression sleeves, socks and hosiery” in International Class 10 (the “Application”), based on
`
`an intent to use said mark.
`
`6.
`
`The Application filing date, and any other date Applicant can rely on, is many
`
`years after Opposer obtained its above-mentioned registrations for its NOVARTIS mark.
`
`7.
`
`The Application filing date, and any other date Applicant can rely on, is also long
`
`after Opposer’s NOVARTIS mark has become famous.
`
`8.
`
`The mark NOVARIS to be registered by Applicant is confusingly similar in
`
`sound, appearance, and commercial impression to Opposer’s registered, long-used and famous
`
`trademark NOVARTIS, in that NOVARIS comprises the NOVARTIS mark but for the letter T.
`
`9.
`
`Moreover, the goods covered in the Application are closely related to products
`
`and services offered by Opposer under its NOVARTIS mark, such that consumer confusion is
`
`likely to result. Namely, Opposer offers pharmaceutical preparations under its NOVARTIS
`
`{F1068234_l
`
`)
`
`2
`
`

`
`mark for the treatment of same or closely related symptoms as those treated by the goods listed
`
`in the Application.
`
`10.
`
`Upon information and belief, Applicant applied to register the NOVARIS mark
`
`with full knowledge of Opposer’s rights to the NOVARTIS mark and with full knowledge of
`
`Opposer’s then-existing federal trademark registrations for the NOVARTIS mark.
`
`1 1.
`
`The registration of Applicant’s mark is inconsistent with Opposer’s prior rights in
`
`the NOVARTIS mark and is inconsistent with Opposer’s statutory grant of exclusivity of use of
`
`the registered NOVARTIS mark, and would destroy Opposer’s investment and goodwill in its
`
`NOVARTIS mark.
`
`12.
`
`The mark NOVARIS sought to be registered by Applicant is so similar to
`
`Opposer’s NOVARTIS mark as to be likely to cause confusion, or to cause mistake, or to
`
`deceive the purchasing public by creating the erroneous impression that Applicant’s goods are
`
`authorized, licensed or sponsored by Opposer, or in some other way connected with Opposer.
`
`As such, any use or registration of the mark NOVARIS by Applicant would violate Section 2(d)
`
`ofthe Lanham Act, 15 U.S.C. § l052(d).
`
`13.
`
`Because Opposer’s NOVARTIS mark is famous, Applicant’s use and registration
`
`of a highly similar mark NOVARIS will dilute the distinctiveness of Opposer’s mark by blurring
`
`or tarnishing it. Accordingly, Applicant’s use and registration of NOVARIS is in violation of
`
`Section 43(0) of the Federal Trademark Act, 15 U.S.C. § 1l25(c).
`
`14.
`
`By reason of the foregoing, Opposer is likely to be harmed by registration of the
`
`Application for Applicant’s Mark.
`
`(Fl0682341 )
`
`3
`
`

`
`WI-IEREFORE, it is respectfully requested that this opposition be sustained -and that the
`
`registration sought by Applicant in Application Serial No. 85/469,498 be denied.
`
`Dated: New York, New York
`August 20, 2012
`
`FROSS ZELNICK LEI-IRMAN & ZISSU, P.C.
`
` 111 P. Margiotta
`
`lexander L. Greenberg
`866 United Nations Plaza
`
`New York, New York 10017
`(212) 813-5900
`jm-argiotta@fzlz.com
`agi'eenberg@fzlz.com
`
`/ltromeysfor the Opposer
`
`Hilllfiflli--I.|
`
`I
`
`4
`
`

`
`EXHIBIT A
`
`

`
`Thank you for your request. Here are the latest results from the TARR web
`server.
`
`This page was generated by the TARR system on 2012-08-16 11:10:34 ET
`
`Serial Number: 75131409 Assignment Information
`Retrieval
`
`Trademark Document
`
`Registration Number: 2336960
`
`Mark (words only): NOVARTIS
`
`Standard Character claim: No
`
`Current Status: The registration has been renewed.
`
`Date of Status: 2010-03-25
`
`Filing Date: 1996-07-09
`
`Transformed into a National Application: No
`
`Registration Date: 2000-04-04
`
`Register: Principal
`
`Law Office Assigned: LAW OFFICE 105
`
`If you are the applicant or applicant's attorney and have questions about this
`file, please contact the Trademark Assistance Center
`at TrademarlmssistanceCcnter@,uspto.gov
`
`Current Location: (NOT AVAILABLE)
`
`Date In Location: 2010-03-25
`
`
`
`LAST APPLICANT(S)/OWNER(S) or RECORD
`
`
`(F|068234 I
`
`)
`
`

`
`l. NOVARTIS AG
`
`Address:
`
`NOVARTIS AG
`
`CH—4002 BASEL
`
`CH—4002 BASEL
`
`Switzerland
`
`Legal Entity Type: Corporation
`State or Country of Incorporation: Switzerland
`
`
`
`GOODS AND/OR SERVICES
`
`
`International Class: 001
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 005
`
`Class Status: Active
`pharmaceutical preparations for the treatment of — dermatological, cardiovascular,
`hematological, bone, respiratory, central nervous system, endocrinological,
`circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds,
`influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic
`disorders, anti-inflammatory agents, immune system disorders and related diseases,
`allergic reactions, metabolic disorders, anti—infectives, occular disorders, and for use
`in oncology; diagnostic preparations and/or reagents for clinical or medical laboratory
`use; Contact lens and eyecare solutions and preparations, namely, disinfectants,
`cleaning solutions, saline solutions and wetting solutions; Nicotine for medicinal
`purposes in liquid, pill, tablet, caplet, powder or transdermal patch form; Dietetic
`substances for medical purposes, namely, nutritional, vitamin, mineral supplements
`and preparations, nutritional drink mix for use as a meal replacement, Food and
`beverages for nfants and invalids, namely, food for enteral administration and food for
`medically restricted diets; and fungicides, and insecticides, all for commercial, and/or
`domestic use
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 009
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`
`{Fl068234 1
`
`)
`
`

`
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 010
`
`Class Status: Section 8 — Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 029
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 030
`
`Class Status: Section 8 — Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 031
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 032
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 042
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`
`
`ADDITIONAL INFORMATION
`
`
`(F1068234 I
`
`)
`
`

`
`Foreign Application Number: 01044/1996
`Foreign Registration Number: 427370
`Foreign Registration Date: 1996-02-15
`Country: Switzerland
`Foreign Filing Date: 1996-02-15
`Foreign Expiration Date: 2006-02-15
`
`
`
`MADRID PROTOCOL INFORMATION
`
`
`(NOT AVAILABLE)
`
`
`
`PROSECUTION HISTORY
`
`NOTE: To—view any document referenced below, click on
`"Trademark Document Retrieval" shown near the top of this page.
`
`2010-03-25 - First renewal 10 year
`
`2010-03-25 - Section 8 (10-year) accepted/ Section 9 granted
`
`2010-03-24 - Case Assigned To Post Registration Paralegal
`
`2010-03-23 - TEAS Section 8 & 9 Received
`
`2006-06-23 - Partial Section 8 (6-year) accepted & Section 15 acknowledged
`
`2006-06-21 - Assigned To Paralegal
`
`2006-04-03 - Section 8 (6-year) and Section 15 Filed
`
`2006-04-12 - Case File In TICRS
`
`2006-04-03 - PAPER RECEIVED
`
`2004-08-05 - PAPER RECEIVED
`
`2000-04-04 - Registered - Principal Register
`
`2000-02-17 - Opposition terminated for Proceeding
`
`2000-02-17 - Opposition dismissed for Proceeding
`
`(Fl068234 1
`
`)
`
`

`
`1998-11-02 - Opposition instituted for Proceeding
`
`1998-08-25 - Opposition papers filed
`
`1998-07-28 - Published for opposition
`
`1998-06-26 — Notice of publication
`
`1998-04-23 - Approved For Pub - Principal Register
`
`1998-03-13 — Communication received from applicant
`
`1998-03-05 — Inquiry as to suspension mailed
`
`1997-09-04 — Letter of suspension mailed
`
`1997-07-10 - Communication received from applicant
`
`1997-01-07 - Non-final action mailed
`
`1996-12-23 - Assigned To Examiner
`
`1996-12-06 - Assigned To Examiner
`
`
`
`ATTORNEY/CORRESPONDENT INFORMATION
`
`
`Attorney of Record
`NANCY SABARRA
`
`Correspondent
`NANCY SABARRA
`
`FROSS ZELNICK LEHRMAN ZISSU, P.C.
`
`866 UNITED NATIONS PLAZA
`
`NEW YORK NY 10017
`
`Domestic Representative
`FROSS ZELNICK LEHRMAN & ZISSU, P.C.
`
`
`
`(F1068234 l
`
`}
`
`

`
`Thank you for your request. Here are the latest results from the TARR web
`server.
`
`This page was generated by the TARR system on 2012-08-16 11:10:34 ET
`
`Serial Number: 75131409 Assignment Information
`Retrieval
`
`Trademark Document
`
`Registration Number: 2336960
`
`Mark (words only): NOVARTIS
`
`Standard Character claim: No
`
`Current Status: The registration has been renewed.
`
`Date of Status: 2010-03-25
`
`Filing Date: 1996-07-09
`
`Transformed into a National Application: No
`
`Registration Date: 2000-04-04
`
`Register: Principal
`
`Law Office Assigned: LAW OFFICE 105
`
`If you are the applicant or applicant's attorney and have questions about this
`file, please contact the Trademark Assistance Center
`at TrademarkAssistanceCenter@,uspto.gov
`
`Current Location: (NOT AVAILABLE)
`
`Date In Location: 2010-03-25
`
`
`
`LAST APPLICANT(S)/OWNER(S) OF RECORD
`
`
`(Fl068234 I
`
`1
`
`

`
`1. NOVARTIS AG
`
`Address:
`
`NOVARTIS AG
`
`CH-4002 BASEL
`
`CH-4002 BASEL
`
`Switzerland
`
`Legal Entity Type: Corporation
`State or Country of Incorporation: Switzerland
`
`
`
`GOODS AND/OR SERVICES
`
`
`International Class: 001
`
`Class Status: Section 8 — Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 005
`
`Class Status: Active
`pharmaceutical preparations for the treatment of - dermatological, cardiovascular,
`hematological, bone, respiratory, central nervous system, endocrinological,
`circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds,
`influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic
`disorders, anti—inflammatory agents, immune system disorders and related diseases,
`allergic reactions, metabolic disorders, anti—infectives, occular disorders, and for use
`in oncology; diagnostic preparations and/or reagents for clinical or medical laboratory
`use; Contact lens and eyecare solutions and preparations, namely, disinfectants,
`cleaning solutions, saline solutions and wetting solutions; Nicotine for medicinal
`purposes in liquid, pill, tablet, caplet, powder or transdermal patch form; Dietetic
`substances for medical purposes, namely, nutritional, vitamin, mineral supplements
`and preparations, nutritional drink mix for use as a meal replacement, Food and
`beverages for nfants and invalids, namely, food for enteral administration and food for
`medically restricted diets; and fungicides, and insecticides, all for commercial, and/or
`domestic use
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 009
`
`Class Status: Section 8 — Cancelled
`
`Basis: 44(e)
`
`{Fl068234l }
`
`

`
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 010
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 029
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 030
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 031
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 032
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
`International Class: 042
`
`Class Status: Section 8 - Cancelled
`
`Basis: 44(e)
`First Use Date: (DATE NOT AVAILABLE)
`First Use in Commerce Date: (DATE NOT AVAILABLE)
`
` #_m.
`
`ADDITIONAL INFORMATION
`
`
`(F|068234 I
`
`)
`
`

`
`Foreign Application Number: 01044/ 1996
`Foreign Registration Number: 427370
`Foreign Registration Date: 1996-02-15
`Country: Switzerland
`Foreign Filing Date: 1996-02-15
`Foreign Expiration Date: 2006-02-15
`
`
`
`MADRID PROTOCOL INFORMATION
`
`
`O\lOT AVAILABLE)
`
`
`
`PROSECUTION HISTORY
`
`To‘View any -document referenced below, click on the linl( to
`"Trademark Document Retrieval" shown near the top of this page.
`
`2010-03-25 - First renewal 10 year
`
`2010-03-25 - Section 8 (10-year) accepted/ Section 9 granted
`
`2010-03-24 - Case Assigned To Post Registration Paralegal
`
`2010-03-23 - TEAS Section 8 & 9 Received
`
`2006-06-23 — Partial Section 8 (6-year) accepted & Section 15 acknowledged
`
`2006-06-21 - Assigned To Paralegal
`
`2006-04-03 - Section 8 (6-year) and Section 15 Filed
`
`2006-04-12 - Case File In TICRS
`
`2006-04-03 — PAPER RECEIVED
`
`2004-08-05 - PAPER RECEIVED
`
`2000-04-04 - Registered - Principal Register
`
`2000-02-17 - Opposition terminated for Proceeding
`
`2000-02-17 — Opposition dismissed for Proceeding
`
`{FI068234 I )
`
`

`
`1998-11-02 - Opposition instituted for Proceeding
`
`1998-08-25 - Opposition papers filed
`
`1998-07-28 - Published for opposition
`
`1998-06-26 - Notice of publication
`
`1998-04-23 - Approved For Pub - Principal Register
`
`1998-03-13 - Communication received from applicant
`
`1998-03-05 - Inquiry as to suspension mailed
`
`1997-09-04 - Letter of suspension mailed
`
`1997-07-10 - Communication received from applicant
`
`1997-01-07 - Non-final action mailed
`
`1996-12-23 - Assigned To Examiner
`
`1996-12-06 - Assigned To Examiner
`
`
`
`ATTORNEY/CORRESPONDENT INFORMATION
`
`
`Attorney of Record
`NANCY SABARRA
`
`Correspondent
`NANCY SABARRA
`
`FROSS ZELNICK LEHRMAN ZISSU, P.C.
`
`866 UNITED NATIONS PLAZA
`
`NEW YORK NY 10017
`
`Domestic Representative
`FROSS ZELNICK LEHRMAN & ZISSU, P.C.
`
`
`
`(Fl0682341 )
`
`

`
`CERTIFICATE OF SERVICE
`
`The undersigned, counsel for Opposer, hereby certifies that a true and correct copy of the
`
`attached NOTICE OF OPPOSITION was served via first class mail, postage prepaid, upon
`
`Applicanfs correspondent of record on this 20"‘ day day of August, 2012, as follows:
`
`Joseph E. Oliver
`Joseph E. Oliver, Co.
`230 White. Pond Drive
`
`Akron, OH 44313-7239
`
`1F I 053234 1
`
`|